IL-10 gene therapy boosts immune attack against liver cancer in mice

Liver-directed AAV-IL-10 therapy activates antitumor CD8⁺ T-cell immunity and suppresses liver cancer growth. Credit: National Taiwan University

Continue Reading


News Source: medicalxpress.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *